UK markets closed

NVO Dec 2021 77.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.27000.0000 (0.00%)
As of 01:54PM EST. Market open.
Full screen
Previous close0.2700
Open0.2700
Bid0.0000
Ask4.8000
Strike77.50
Expiry date2021-12-17
Day's range0.2700 - 0.2700
Contract rangeN/A
Volume3
Open interest210
  • Zacks

    GSK vs. NVO: Which Stock Should Value Investors Buy Now?

    GSK vs. NVO: Which Stock Is the Better Value Option?

  • Globe Newswire

    Novo Nordisk A/S – Share repurchase programme

    Bagsværd, Denmark, 29 November 2021 – On 5 November 2021, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 3 February 2021. Under the programm

  • Reuters

    Novo Nordisk says lower insulin prices in China dent 2022 outlook

    Novo Nordisk on Friday forecast its sales growth would slow by about 3% in 2022 because of lower prices and a drop in insulin sales volumes in China, denting the Danish diabetes drug maker's share price. The forecast comes after Novo received results from China's Volume Based Procurement (VBP) tender, which covers insulin sold at Chinese hospitals. "Novo Nordisk currently expects an estimated negative impact on global sales growth of around 3% in 2022 as a result of reduced prices and reduced volumes of insulin sold in China," it said in a statement.